CRMMF News Alert CRH Medical Corp (CRMMF) 0.6240 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CRH Medical Corp (CRMMF) 0.6240 $CRMMF

CRH Medical Announces Second Quarter 2014 Results
CNW Group - Wed Jul 30, 4:00PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced its unaudited financial results for its second quarter, ended June 30, 2014. All financial results are expressed in U.S dollars.

CRH Medical Announces Voting Results of Shareholders Meeting
CNW Group - Fri Jun 20, 6:00AM CDT
CRH Medical Corporation (the "Company" (TSX: CRH) (OTCQX: CRMMF), announces the following voting results for the Company's 2014 Annual Meeting of Shareholders (the "Meeting" . At the Meeting, the nominees listed in the Company's management proxy circular were re-elected as directors, KPMG LLP was appointed as auditor of the Company for the coming year and certain other resolutions were passed as discussed below.

CRH Medical Announces Fiscal 2013 Results
CNW Group - Wed Mar 19, 6:12AM CDT
- Also Announces Date for First Quarter 2014 Results -

Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Common Shares in the Capital of CRH Medical Corporation
Marketwire - Tue Jan 07, 3:01PM CST
Fernbank LLC ("Fernbank" announces that following a set of transactions ending on January 6, 2014 which were conducted through the facilities of the Toronto Stock Exchange, it acquired 108,900 common shares (the "Acquisition" of CRH Medical Corporation ("CRH" or the "Corporation" . Immediately following the Acquisition, Fernbank owned, controlled and had direction over an aggregate of 4,905,900 common shares of the Corporation on a non-diluted basis, representing approximately 10.1% of CRH's outstanding common shares at that time.

CRH Medical Announces Second Quarter Results
CNW Group - Mon Jul 22, 4:00PM CDT
Revenue Increases 16% Compared to Same Period Last Year

CRH Medical Announces Re-Election of Directors and Auditor
CNW Group - Thu Jun 20, 5:28PM CDT
CRH Medical Corporation (the "Company" (TSX: CRH) (OTCQX: CRMMF), announces that the nominees listed in the management proxy circular for the 2013 Annual Meeting of Shareholders were re-elected as directors.

CRH Medical To Present at Bloom Burton & Co. Healthcare Investor Conference
CNW Group - Thu May 09, 12:30PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that Edward Wright, the Company's Chief Executive Officer, will present at the second annual Bloom Burton & Co. Healthcare Investor Conference on Wednesday, May 22, at 3:00 pm Eastern Time. The conference will be held at the Toronto Board of Trade in Toronto, Ontario.

CRH Medical Announces First Quarter Results
CNW Group - Tue Apr 23, 3:00PM CDT
-First Quarter Revenue Increases 9% Compared to Same Period Last Year -

CRH Medical announces anticipated revenue for the year ending December 31, 2012
CNW Group - Tue Jan 15, 6:00AM CST
CRH Medical Corporation (TSX: CRH), (OTCQX: CRMMF), a North American medical company focused on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it expects to reportrevenue for the year ended December 31, 2012 of approximately US$6,850,000.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
AI Agents Redefine Finance: Deutsche & Ant Tech

Updated Category News Views 42

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 151

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 50

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 723

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 124

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading

Top 5 Most Recently Viewed Articles

Westgold Resources Initiates Mining Operations at South Junction

Updated Category News Views 110

Westgold Resources Launches Mining Operations at South Junction Westgold Resources Limited (ASX: WGX, OTCQX: WGXRF) has officially kicked off mining activities at the South Junction Lode, which is part of its Bluebird-South Junction mining complex located in Meekatharra. This marks an important milestone for the company as it aims to boost production in this crucial area....

Continue Reading
Inspira Apartments: A Florida Gem hits the Market

Updated Category News Views 37

Spotlight on Inspira Apartments in Naples Alright folks, Naples isn't just about sunshine and retirees lounging in their flip-flops. A real estate ripper-known as JBM® just threw the Inspira Apartments into the investment ring, with a Call For Offers set for July 30th, 2026. This isn’t your average cookie-cutter deal; it’s a top-tier, institutional-grade gem with 304...

Continue Reading
TechSee Welcomes Domenico D'Ambrosio to Advisory Board to Enhance AI Strategy

Updated Category News Views 233

TechSee Strengthens Advisory Board with Key Appointment TechSee, a household name in the telecom and technology landscape, is taking a significant step towards redefining customer experiences by welcoming Domenico D'Ambrosio to its Advisory Board. This strategic move aims to enhance the direction of the company as it ventures deeper into the world of Agentic AI, a...

Continue Reading
Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test

Updated Category News Views 256

Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test Human Longevity, Inc. (HLI), a frontrunner in the field of precision health, has recently enhanced its cancer prevention offerings. The company has introduced the ClearNote Health Avantect Pancreatic Cancer Test into its portfolio, designed to assist clients in detecting pancreatic cancer in its early stages....

Continue Reading
Idorsia Moves Forward After Ending Aprocitentan Exclusivity Deal

Updated Category News Views 408

Idorsia Announces Conclusion of Aprocitentan Exclusivity Agreement Idorsia Ltd has recently made a significant announcement regarding their drug, aprocitentan. The exclusivity agreement that was in place since November 2024 with an undisclosed partner has come to an end. This development was confirmed as the prospective partner chose not to finalize the deal, which...

Continue Reading